Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Clinical trials demonstrate improvements in several metabolic parameters, including reduced hemoglobin A1c levels (typically 1.0-1.6% depending on baseline levels and dosage), decreased fasting plasma glucose, and modest improvements in lipid profiles
The most common hypersensitivity reactions were rash (1.0% versus 0.5% for REPATHA and placebo, respectively), eczema (0.4% versus 0.2%), erythema (0.4% versus 0.2%), and urticaria (0.4% versus 0.1%)
Water, Ethylhexyl Palmitate, Glycereth-26, Glycerin, Cetearyl Alcohol, Niacinamide, Hydrogenated Poly(C6-14 Olefin), Beeswax, Caprylic/Capric Triglyceride, Polyglyceryl-2 Stearate, Dipropylene Glycol, Isododecane, Glyceryl Stearate, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Stearyl Alcohol, Glycol Stearate SE, Sodium Polyacrylate, Hydroxyacetophenone, Stearic Acid, Dimethiconol, Dimethicone/Vinyl dimethicone crosspolymer, Hydrogenated Polydecene, Hydrogenated Lecithin, Tranexamic Acid (1,000ppm), Betaine, Glutathione (1,000ppm), Panthenol, Fragrance, Hippophae Rhamnoides Fruit Oil, Butylene Glycol, Adenosine, Sorbitan Isostearate, Caprylyl Glycol, Trideceth-6, 1,2-Hexanediol, Disodium EDTA, Sodium Hyaluronate, Ascorbic Acid
Melanotan II exhibits neuroprotective and anti-inflammatory properties by regulating cytokine activity and reducing reactive oxygen species formation
What the trials showed In the phase 2 trial, injection site reactions with cagrilintide occurred at dramatically higher rates than placebo
Use a thermometer: If you want to be precise, place a small refrigerator thermometer near your medication to ensure it stays within the safe range
